Neurology

Your Article Summary

See Latest Articles

Use of antipsychotics in neuropsychiatric symptoms of dementia
Geriatrics, 05/18/09

Kalapatapu RK et al. - Antipsychotic medications have a modest effect on the neuropsychiatric symptoms of dementia, but product labels warn of the excess risk of death and morbidity associated with their use in older patients. As such, these agents should not be the first choice for the treatment of behavioral and psychotic symptoms of dementia. Nevertheless, a trial of these agents may be indicated in instances in which the severity of symptoms is extreme, or symptoms do not respond to nonpharmacologic methods or other medications...There is no evidence to suggest differences in effectiveness between atypical and conventional antipsychotics; therefore, the choice of an antipsychotic for neuropsychiatric symptoms often relies on side effect profile and individual patient circumstances. Extrapyramidal symptoms and QTc prolongation are concerns with conventional antipsychotic agents. The incidence of cerebrovascular events with either atypical or conventional antipsychotics appears increased compared with placebo. A discussion of the risk-benefit ratio of antipsychotics with the patient's family and/or caregivers should precede the decision to use these agents.

Related Articles

See all related articles

Prevalence of dementia and major dementia subtypes in Spanish populations: A reanalysis of dementia prevalence surveys, 1990-2008
BMC Neurology, 10/23/09    Relevance Score: 94%

High Prevalence of Orthostatic Hypotension in Mild Dementia
Dementia and Geriatric Cognitive Disorders, 10/15/09    Relevance Score: 93%

Predicting dementia: role of dementia risk indices
Future Neurology, 10/02/09    Relevance Score: 93%

Lipids peroxidation markers in Alzheimer's disease and vascular dementia
Geriatrics and Gerontology International, 11/17/09    Relevance Score: 91%

Promiscuous modulation of ion channels by anti-psychotic and anti-dementia medications
Medical Hypotheses, 10/05/09    Relevance Score: 91%

Today in Dementia...keeping you current

Receive free subspecialty "5-minute updates" via email

Behavioural and psychological symptoms in vascular dementia; differences between small and large vessel disease
Journal of Neurology, Neurosurgery, and Psychiatry , 12/11/09

Behavioral Dimensions and Acetylcholinesterase Inhibitor-related Effect in Alzheimer Disease Over Time: A Latent Trajectory Modeling
Cognitive and Behavioral Neurology, 12/11/09

Disturbances in Everyday Life Activities and Sequence Disabilities in Tool use for Alzheimer Disease and Vascular Dementia
Cognitive and Behavioral Neurology, 12/11/09

 See all of Dementia

Today in Neuro/Psych pharmacology...keeping you current

Receive free subspecialty "5-minute updates" via email

Natalizumab treatment in multiple sclerosis: Marked decline of chemokines and cytokines in cerebrospinal fluid
Multiple Sclerosis, 12/11/09

Behavioral Dimensions and Acetylcholinesterase Inhibitor-related Effect in Alzheimer Disease Over Time: A Latent Trajectory Modeling
Cognitive and Behavioral Neurology, 12/11/09

Depression in Parkinson's Disease
Canadian Journal of Neurological Sciences, 12/10/09

 See all of Neuro/Psych pharmacology

Today in Neuropsych Sciences...keeping you current

Receive free subspecialty "5-minute updates" via email

Catatonia: Clinical Aspects and Neurobiological Correlates
Journal of Neuropsychiatry and Clinical Neurosciences, 12/11/09

Psychopharmacological Treatment for Cognitive Impairment in Survivors of Traumatic Brain Injury: A Critical Review
Journal of Neuropsychiatry and Clinical Neurosciences, 12/11/09

Heterogeneity of DSM-IV Major Depressive Disorder as a Consequence of Subthreshold Bipolarity
Archives of General Psychiatry, 12/11/09

 See all of Neuropsych Sciences